{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T17:53:33Z","timestamp":1778954013196,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.humpath.2018.10.013","type":"journal-article","created":{"date-parts":[[2018,10,28]],"date-time":"2018-10-28T21:41:36Z","timestamp":1540762896000},"page":"18-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma"],"prefix":"10.1016","volume":"85","author":[{"given":"Iv\u00e1n","family":"Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bella","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle D.","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reetesh K.","family":"Pai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changqing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2018.10.013_bb0005","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1245\/s10434-011-2173-6","article-title":"A population-based comparison of adenocarcinoma of the large and small intestine: insights into a rare disease","volume":"19","author":"Overman","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2018.10.013_bb0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/SLA.0b013e31818e4641","article-title":"Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years","volume":"249","author":"Bilimoria","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.humpath.2018.10.013_bb0015","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1038\/bjc.2013.677","article-title":"Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study","volume":"109","author":"Aparicio","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2018.10.013_bb0020","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.gtc.2016.04.004","article-title":"Small bowel adenocarcinoma","volume":"45","author":"Aparicio","year":"2016","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.humpath.2018.10.013_bb0025","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.onc.1205041","article-title":"Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene","volume":"21","author":"Blaker","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2018.10.013_bb0030","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.ejca.2014.04.007","article-title":"ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma","volume":"50","author":"Laforest","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2018.10.013_bb0035","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/sj.bjc.6605449","article-title":"Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine","volume":"102","author":"Overman","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2018.10.013_bb0040","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/cncr.11197","article-title":"Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine","volume":"97","author":"Planck","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2018.10.013_bb0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0016-5085(97)70087-8","article-title":"Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine","volume":"113","author":"Rashid","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humpath.2018.10.013_bb0050","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/jcp.56.12.898","article-title":"Immunohistochemical analysis of adenocarcinoma of the small intestine: a tissue microarray study","volume":"56","author":"Svrcek","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2018.10.013_bb0055","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/gut.50.2.218","article-title":"An insight into the genetic pathway of adenocarcinoma of the small intestine","volume":"50","author":"Wheeler","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.humpath.2018.10.013_bb0060","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/PAI.0000000000000389","article-title":"Small bowel adenocarcinoma frequently exhibits Lynch syndrome\u2013associated mismatch repair protein deficiency but does not harbor sporadic MLH1 deficiency","volume":"25","author":"Xia","year":"2017","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2018.10.013_bb0065","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1200\/JCO.2009.27.1825","article-title":"Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer","volume":"28","author":"Sargent","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2018.10.013_bb0070","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.1158\/1078-0432.CCR-11-1048","article-title":"Defective mismatch repair status as a prognostic biomarker of disease-free survival in stage III colon cancer patients treated with adjuvant FOLFOX chemotherapy","volume":"17","author":"Zaanan","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2018.10.013_bb0075","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.canlet.2003.08.013","article-title":"Prognostic significance of microsatellite instability in curatively resected adenocarcinoma of the small intestine","volume":"203","author":"Brueckl","year":"2004","journal-title":"Cancer Lett"},{"key":"10.1016\/j.humpath.2018.10.013_bb0080","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1158\/1078-0432.CCR-12-0707","article-title":"CpG island methylator phenotype-positive tumors in the absence of MLH1 methylation constitute a distinct subset of duodenal adenocarcinomas and are associated with poor prognosis","volume":"18","author":"Fu","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2018.10.013_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162929","article-title":"Methylation of MGMT is associated with poor prognosis in patients with stage III duodenal adenocarcinoma","volume":"11","author":"Fu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2018.10.013_bb0090","first-page":"2228","article-title":"Expression of hMLH1, hMSH2 and hMSH6 in small intestinal carcinomas","volume":"59","author":"Gu","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.humpath.2018.10.013_bb0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-pathol-012414-040445","article-title":"SWI\/SNF chromatin remodeling and human malignancies","volume":"10","author":"Masliah-Planchon","year":"2015","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.humpath.2018.10.013_bb0100","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1158\/0008-5472.CAN-11-1562","article-title":"ARID1A, a factor that promotes formation of SWI\/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers","volume":"71","author":"Guan","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2018.10.013_bb0105","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","author":"The Cancer Genome Atlas Network","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2018.10.013_bb0110","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/humu.21633","article-title":"Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types","volume":"33","author":"Jones","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.humpath.2018.10.013_bb0115","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.humpath.2014.04.009","article-title":"Loss of ARID1A expression in colorectal carcinoma is strongly associated with mismatch repair deficiency","volume":"45","author":"Chou","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2018.10.013_bb0120","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.humpath.2014.08.007","article-title":"Immunohistochemical detection of ARID1A in colorectal carcinoma: loss of staining is associated with sporadic microsatellite unstable tumors with medullary histology and high TNM stage","volume":"45","author":"Ye","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2018.10.013_bb0125","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00428-012-1303-2","article-title":"ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein-Barr virus infection and microsatellite instability","volume":"461","author":"Abe","year":"2012","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2018.10.013_bb0130","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/his.12566","article-title":"Loss of ARID1A expression is associated with poor prognosis in small intestinal carcinoma","volume":"66","author":"Kim","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2018.10.013_bb0135","series-title":"WHO classification of tumours of the digestive system","first-page":"98","article-title":"Carcinoma of the small intestine","author":"Shepherd","year":"2010"},{"key":"10.1016\/j.humpath.2018.10.013_bb0140","series-title":"AJCC cancer staging manual","year":"2010"},{"key":"10.1016\/j.humpath.2018.10.013_bb0145","series-title":"AJCC cancer staging manual","year":"2017"},{"key":"10.1016\/j.humpath.2018.10.013_bb0150","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/PAS.0b013e318212782a","article-title":"Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma","volume":"35","author":"Guan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2018.10.013_bb0155","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S1470-2045(08)70232-8","article-title":"Small-bowel cancer in lynch syndrome: is it time for surveillance?","volume":"9","author":"Koornstra","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2018.10.013_bb0160","author":"The United States Food and Drug Administration"},{"key":"10.1016\/j.humpath.2018.10.013_bb0165","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.humpath.2018.10.013_bb0170","doi-asserted-by":"crossref","first-page":"20863","DOI":"10.18632\/oncotarget.4576","article-title":"Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility","volume":"6","author":"Alvi","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2018.10.013_bb0175","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jamaoncol.2017.1051","article-title":"Genomic profiling of small-bowel adenocarcinoma","volume":"3","author":"Schrock","year":"2017","journal-title":"JAMA Oncol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817718304106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817718304106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T11:59:15Z","timestamp":1554551955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817718304106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":35,"alternative-id":["S0046817718304106"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2018.10.013","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2018.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}